首页> 外文OA文献 >Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

【2h】

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

机译：慢性丙型肝炎病毒感染患者直接作用抗病毒治疗的疗效和安全性：中国天津的真实单中心经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Huan Xia; Chengzhen Lu; Yin Wang; Silvere D. Zaongo; Yue Hu; Yue Wu; Zhongfang Yan; Ping Ma;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of direct-acting antiviral agent regimens in a real-world cohort of adult Chinese patients with chronic hepatitis C virus infection [J] . Jinyuan Wei, Yongyu Mei, Jianping Li, Liver research. . 2020,第2期

机译：直效抗病毒药方案在真正世界慢性丙型肝炎病毒感染患者中的直效抗病毒药方案的疗效和安全性
2. Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort [J] . Sebastian Bernuth, Daniel Grimm, Johanna Vollmar, Drug Design, Development and Therapy . 2017,第5期

机译：直接作用抗病毒治疗对先前难治性肝移植术后复发性丙型肝炎病毒感染患者的疗效和安全性：一个真实的队列
3. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis [J] . Toyoda Hidenori, Kumada Takashi, Tada Toshifumi, Journal of gastroenterology . 2016,第7期

机译：血液透析患者双重直接作用抗病毒治疗（达卡他韦和阿舒那韦）对慢性丙型肝炎病毒基因型1感染的安全性和有效性
4. MALDI-TOF MS for Monitoring Drug Resistance in Hepatitis B Virus-Infected Patients during Antiviral Therapy [C] . Magda Rybicka, Piotr Stalke, Tomasz Smiatacz, International Mass Spectrometry Conference . 2014

机译：MALDI-TOF MS用于监测抗病毒治疗期间乙型肝炎病毒感染患者耐药性的MS
5. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
6. Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin China [O] . Huan Xia, Chengzhen Lu, Yin Wang, 2020

机译：直接作用抗病毒治疗对慢性丙型肝炎病毒感染患者的疗效和安全性：中国天津市的单中心实战经验
7. Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis [O] . Hidenori Toyoda, Takashi Kumada, Toshifumi Tada, 2016

机译：误解：双直效抗病毒治疗的安全性和有效性（Daclatasvir和Asunaprevir）用于血液透析患者慢性丙型肝炎病毒基因型1感染

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

著录项

引文网络

相似文献

相关主题

期刊订阅